Assessment of Clinical Characteristics and Outcomes of Liver Diseases Unique to Pregnancy at a Tertiary Hospital in Ethiopia: A Retrospective Cohort Study
Table 4
Maternal and neonatal outcomes of liver disease specific to pregnancy.
PE/E with liver dysfunction (%)
HELLP syndrome (%)
AFLP (%)
HG with liver dysfunction (%)
Total (%)
value (HELLP syndrome+AFLP)
Cesarean section
21 (48.8%)
16 (45.7%)
2 (28.6%)
1 (11.1%)
40 (42.1%)
0.895
AKI on dialysis
1 (2.3%)
6 (17.1%)
2 (28.6%)
—
9 (9.5%)
0.009
Abruption of placenta
1 (2.3%)
7 (20%)
2 (28.6%)
—
10 (10.5%)
0.004
Liver hematoma or rupture
—
1 (2.9%)
—
—
1 (1.1%)
0.442
ICU admission
2 (4.7%)
16 (45.7%)
5 (71.4%)
—
23 (24.2%)
0.001
Maternal death
—
3 (8.6%)
1 (14.3%)
—
4 (4.2%)
0.035
Miscarriage
4 (9.3%)
2 (5.7%)
—
—
6 (6.3%)
0.907
Neonatal ICU admission
9 (20.9%)
5 (14.3%)
2 (28.6%)
—
16 (16.8%)
0.849
Early neonatal death
2 (4.7%)
2 (5.7%)
—
—
4 (4.2%)
1.000
Stillbirth
5 (11.6%)
13 (37.1%)
5 (71.4%)
—
23 (24.2%)
0.001
PE/E: preeclampsia/eclampsia; HELLP: hemolysis elevated liver enzyme and low platelet; AFLP: acute fatty liver of pregnancy; HG: hyperemesis gravidarum; AKI: acute kidney injury; ICU: intensive critical care unit.
